BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33314017)

  • 21. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.
    Chen D; Law ME; Theis JD; Gamez JD; Caron LB; Vrana JA; Dogan A
    Am J Surg Pathol; 2009 May; 33(5):720-9. PubMed ID: 19145199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on genetic aberrations of ocular mucosa-associated lymphoid tissue lymphomas occurring in southern China].
    Zhang XM; Zhang WY; Zhou YP; Mo XL; Li YP; Wang GQ; Zhou YQ; Zeng SE; Li GD; Ye HT
    Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):513-7. PubMed ID: 21055028
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Carbo-Meix A; Guijarro F; Wang L; Grau M; Royo R; Frigola G; Playa-Albinyana H; Buhler MM; Clot G; Duran-Ferrer M; Lu J; Granada I; Baptista MJ; Navarro JT; Espinet B; Puiggros A; Tapia G; Bandiera L; De Canal G; Bonoldi E; Climent F; Ribera-Cortada I; Fernandez-Caballero M; De la Banda E; Do Nascimento J; Pineda A; Vela D; Rozman M; Aymerich M; Syrykh C; Brousset P; Perera M; Yanez L; Ortin JX; Tuset E; Zenz T; Cook JR; Swerdlow SH; Martin-Subero JI; Colomer D; Matutes E; Bea S; Costa D; Nadeu F; Campo E
    Haematologica; 2024 Feb; 109(2):493-508. PubMed ID: 37560801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
    Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus.
    Li K; Johnson RL; Li S; Thorson JA; Mulroney CM; Dell'Aquila ML; Wang HY
    Int J Clin Exp Pathol; 2014; 7(8):5221-31. PubMed ID: 25197401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining the borders of splenic marginal zone lymphoma: a multiparameter study.
    Dufresne SD; Felgar RE; Sargent RL; Surti U; Gollin SM; McPhail ED; Cook JR; Swerdlow SH
    Hum Pathol; 2010 Apr; 41(4):540-51. PubMed ID: 20004934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma.
    Stein L; Bacmeister C; Ylaya K; Fetsch P; Wang Z; Hewitt SM; Kiupel M
    Vet Pathol; 2019 May; 56(3):350-357. PubMed ID: 30636524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
    Hamadeh F; MacNamara SP; Aguilera NS; Swerdlow SH; Cook JR
    Mod Pathol; 2015 Apr; 28(4):564-74. PubMed ID: 25216226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma.
    Cuneo A; Bardi A; Wlodarska I; Selleslag D; Roberti MG; Bigoni R; Cavazzini F; De Angeli C; Tammiso E; del Senno L; Cavazzini P; Hagemeijer A; Castoldi G
    Leukemia; 2001 Aug; 15(8):1262-7. PubMed ID: 11480569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
    Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
    Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.
    Solé F; Salido M; Espinet B; Garcia JL; Martinez Climent JA; Granada I; Hernández JM; Benet I; Piris MA; Mollejo M; Martinez P; Vallespí T; Domingo A; Serrano S; Woessner S; Florensa L
    Haematologica; 2001 Jan; 86(1):71-7. PubMed ID: 11146574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.
    Martinez D; Navarro A; Martinez-Trillos A; Molina-Urra R; Gonzalez-Farre B; Salaverria I; Nadeu F; Enjuanes A; Clot G; Costa D; Carrio A; Villamor N; Colomer D; Martinez A; Bens S; Siebert R; Wotherspoon A; Beà S; Matutes E; Campo E
    Am J Surg Pathol; 2016 Feb; 40(2):192-201. PubMed ID: 26426381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR.
    Rizzo KA; Streubel B; Pittaluga S; Chott A; Xi L; Raffeld M; Jaffe ES
    Mod Pathol; 2010 Jun; 23(6):866-73. PubMed ID: 20305621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
    Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F
    Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia.
    Brito-Babapulle V; Gruszka-Westwood AM; Platt G; Andersen CL; Elnenaei MO; Matutes E; Wotherspoon AC; Weston-Smith SG; Catovsky D
    Haematologica; 2002 Apr; 87(4):357-62. PubMed ID: 11940479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
    Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.